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Abstract
Background: Several studies have shown a relatively high mortality rate among young people infected by the 2009 
pandemic influenza A (H1N1) virus. Here we compared the age distributions of morbidity and mortality during two 
seasonal influenza epidemics (H1N1 and H3N2) in France and the United States with those of the 2009 H1N1 pandemic 
waves in the same countries.
Methods: Age-standardized ratios were used to compare the age distribution of morbidity and mortality due to 
influenza between the two countries and across the different years. Non parametric analysis of variance was used to 
compare these ratios between epidemic and pandemic influenza.
Results: Age distribution of morbidity was similar between the 2009 pandemic and seasonal epidemics due to H1N1 
(p = 0.72) and H3N2 viruses (p = 0.68). In contrast, the proportion of under-60s among influenza deaths was markedly 
higher during the 2009 pandemic (peak <20 years) than during the seasonal epidemics (respectively p = 0.007 and p = 
0.0008).
Conclusions: Young age was a principal mortality risk factor due to the 2009 H1N1 pandemic.
Background
The 2009 pandemic influenza A (H1N1) virus (2009
pH1N1) emerged in April 2009 in the Americas and sub-
sequently spread worldwide [1]. Preliminary findings in
Mexico and the United States suggested that people aged
from 5 to 30 years were at a higher risk of infection, while
those aged 30 to 50 years old were at a higher risk of
death [2-4]. The risk of infection and death seemed to be
lower in the elderly population, a finding attributed to
prior exposure to A/H1N1 viruses that circulated before
1957 [5,6]. During seasonal epidemics, mortality is classi-
cally highest in the elderly population. Conversely, during
pandemic influenza mortality is highest in younger age
groups. This shift of mortality toward younger age groups
is considered as a signature feature of pandemics [7]. Few
comparative studies are available on age distribution of
morbidity during pandemic and seasonal influenza. Stud-
ies of the 1918, 1957 and 1968 pandemics suggest that the
age distribution of morbidity was similar to that of sea-
sonal influenza, but no direct comparisons are available
[8,9]. Here we examined the age distribution of morbidity
and mortality during seasonal influenza epidemics
(H1N1 and H3N2) in the US and France by comparison
with the 2009 H1N1 pandemic in the same countries.
Methods
Periods
We selected two seasonal influenza epidemics (H1N1 and
H3N2) in the US and France, which were due to single
viral strains and for which nationwide mortality and mor-
bidity data were available.
The seasonal H1N1 epidemics were those of 1978-79
(A/USSR/90/77) in the US [8] and 1988-89 (A/SING/1/
87) in France, while the seasonal H3N2 epidemics were
those of 1989-90 (A/Shanghai/11/87) in the two countries
[10].
The periods of the 2009 H1N1 pandemic were April
2009 to January 2010 in the US [11] and from September
2009 to January 2010 in France [12].
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Influenza data
We chose influenza-like illness (ILI) as the sole indicator
of morbidity. The dates of the US seasonal epidemics and
the age distribution of ILI were extracted from published
studies [8,13]. The French data were obtained from the
Sentinel system [12], created in 1984. The latter is a
nationwide network of general practitioners who report,
in real time, the number of medical visits for ILI.
The US ILI case definition consisted of fever and cough
or sore throat. The French consisted of fever >39°C,
aches, and sore throat. Influenza was not virologically
confirmed in the French dataset, while it was virologically
confirmed in the US for the H1N1 epidemic in 1978-79
and the H3N2 epidemic in 1989-90.
The age distributions of ILI during the 2009 pandemic
in the US were collected from the Centers for Disease
Control and Prevention [11,14]. In France, the age distri-
bution of ILI during the pandemic was collected from the
Sentinel system [12].
The age distributions of influenza-related mortality
were obtained from national death registries: the
National Bureau of Economic Research for the US [15]
and the Centre d'épidémiologie des causes médicales de
décès for France [16]. Influenza was identified using
codes 470 to 474 of the International Classification of
Diseases (ICD) 8th revision before 1979, and code 487 of
the 9th revision thereafter.
The age distributions of influenza-related mortality
during the 2009 H1N1 pandemic were collected from the
Centers for Disease Control and Prevention (CDC) [17]
in the US and from the French equivalent of the CDC
(Institut de Veille Sanitaire) in France [18].
Demographic data
We used yearly population data obtained from regular
censuses. The age distribution of the national populations
was obtained from the National Cancer Institute Surveil-
lance Epidemiology and End Results for the US [19] and
t h e  I n s t i t u t  N a t i o n a l  d e  l a  S t a t i s t i q u e  e t  d e s  E t u d e s
Economiques for France [20].
The age distributions of all-cause deaths were obtained
from the national death registries for seasonal epidemic
periods [15,16]. As the 2009 data were not yet available at
the time of the study, we used 2004/2005 mortality data -
the most recent period in the WHO database [21].
Ratios
We calculated age-standardized ratios (Relative Illness
Ratio and Relative Mortality Ratio) in order to compare
the age distribution of morbidity and mortality due to
influenza between the two countries and between sea-
sonal influenza epidemic and influenza pandemic. We
first calculated the relative illness ratio (RIR), as the ratio
of the percentage of sick persons in a given age group to
the percentage of the general population belonging to the
same age group. We then calculated the ratio between the
percentage of influenza deaths in a given age group and
the percentage of all-cause deaths in the same age group,
yielding the relative mortality ratio (RMR). For both these
ratios, a ratio above 1 indicates an excess risk.
The ratios were calculated as follows:
Relative Illness Ratio (RIR): (Ci/Σ Ci)/(Ni/Σ Ni)
Ci: number of cases of influenza-like illness in a given
age group
Σ Ci: Sum of cases of influenza-like illness in all age
groups
Ni: Population in a given age group
Σ Ni: Sum of populations in all age groups.
Relative Mortality Ratio (RMR): (Ii/Σ Ii)/(Di/Σ Di)
Ii: number of influenza deaths in a given age group
Σ Ii: Sum of influenza deaths in all age groups
Di: Number of all-cause deaths in a given age group
Σ Di: Sum of all-cause deaths in all age groups.
Statistical analysis
Confidence intervals for the RIR and RMR were calcu-
lated with an exact method based on the Poisson distri-
bution [22]. Non parametric analysis of variance
(Kruskall-Wallis test) was used to compare RIR and RMR
values between epidemic and pandemic influenza. All
statistical tests were two-tailed, with a type I error of 5%.
Results
The RIRs are shown in figure 1 according to age. Overall,
the 2009 H1N1 pandemic in the US and France resem-
bled the seasonal epidemics of H1N1 (p = 0.72) and
H3N2 influenza (p = 0.68).
Interestingly, the 2009 H1N1 pandemic was associated
with RIRs above 1 among people under 35 years of age.
Maximal RIR values of 2.97 (95% CI 1.76-4.71) and 3.49
(95% CI 2.23-5.20), respectively, were obtained for the 5-
to 9-year age group in France and for the 0- to 4-year age
group in the US. The maximal RIR values for the seasonal
epidemics in France were obtained for the 5- to 9-year
age group during the 1988-89 H1N1 epidemic (2.15 (95%
CI 1.20-3.56)) and the 5- to 9-year age group during the
1989-90 H3N2 epidemic (1.77 (95% CI 0.92-3.09)). In the
US, the maximal RIR values were for the 10- to 14-year
age group during the 1978-79 H1N1 epidemic (2.99 (95%
CI 1.92-4.43)) and the 5- to 24-year age group during the
1989-90 H3N2 epidemic (1.84 (95% CI 1.38-2.41)). All
RIRs for people aged 35 years or more were below 1.
Overall, the RMRs differed strongly between the 2009
H1N1 pandemic and the seasonal H1N1 (p = 0.007) and
H3N2 epidemics (p = 0.0008) (figure 2).
RMRs above 1 were consistently observed among peo-
ple under 60 years of age during the 2009 H1N1 pan-Lemaitre and Carrat BMC Infectious Diseases 2010, 10:162
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demic waves, with maxima under 20 years of age. The
maximal RMR values were 38.66 (95% CI 35.76-41.75) in
the 5- to 24-year age group in the US and 37.39 (95% CI
24.40-54.83) in the 5- to 9-year age group in France.
Even though the RMR was above 1 for people under 60
years, the RMR fell significantly between the ages of 20
and 60 years (p = 0.04).
In contrast, during the seasonal epidemics, RMRs
above 1 were consistently observed among people over 65
years of age. The RMR maxima in France were 1.12 (95%
CI 1.04-1.20) during the 1988-89 H1N1 epidemic and
1.20 (95% CI 1.13-1.28) during the 1989-90 H3N2 epi-
demic; in the US, the maximal RMR value was 1.22 (95%
CI 1.14-1.31) during the seasonal H3N2 epidemic. Dur-
ing the 1978-79 seasonal H1N1 epidemic in the US, the
maximal RMR was in the 5- to 24-year age group (3.91
(95% CI 1.94-7.02)).
Discussion
Although the age distribution of morbidity due to influ-
enza was similar during the 2009 H1N1 pandemic waves
and seasonal epidemics in the US and France, the age dis-
tribution of influenza mortality differed markedly. As
reported ILI incidence rates for the 2009 H1N1 pandemic
are unreliable, we chose to analyze the age distribution of
ILI. For consistency, we used a similar method to analyze
mortality data. However, it should be pointed out that the
calculated relative illness and death ratios provide no
information on the morbidity or mortality burden of
influenza in the general population.
Our objective was to compare the age distributions of
ILI between pandemic influenza and seasonal epidemics,
and not to compare the burden of ILI (i.e. the cumulative
incidence rates) between the US and France. The two
data sources are not comparable, as some cases of ILI
without virological confirmation could have been due to
respiratory pathogens other than influenza virus. How-
ever, it is worth noting that the age distribution of these
two sources of seasonal ILI (one virologically confirmed,
the other not) were very similar, indicating no age-related
bias in the dataset for ILI without virological confirma-
Figure 1 Relative illness ratio (RIR) across age groups. The RIR is 
the ratio of the percentage of sick persons in a given age group to 
the percentage of the general population belonging to the same 
age group. The age distribution of morbidity were established from 
data based on cohorts of 6,000 patients during the 1978-79 seasonal 
epidemic and 59,785 patients during the 1989-90 seasonal epidemic in 
the US. The age distribution of morbidity were obtained from the re-
port of 18,839 (1988-89) and 27,054 (1989-90) cases in France. Pan-
demic age-distribution were obtained from 11,485 (France) and 
658,078 (US) cases.
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Figure 2 Relative mortality ratio (RMR) across age groups. The 
RMR is the ratio between the percentage of influenza deaths in a 
given age group and the percentage of all-cause deaths in the 
same age group. The age distribution of mortality due to influenza 
were established from the report of 368 influenza deaths during the 
1978-79 seasonal epidemic and 1,926 influenza deaths during the 
1989-90 seasonal epidemic in the US. The age distribution of mortality 
due to influenza were obtained from the report of 508 (1988-89) and 
1,990 (1989-90) influenza deaths in France. Pandemic age-distribution 
were obtained from 308 (France) and 6,317 (US) influenza deaths.
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tion and no difference between the risk of infection and
risk of ILI. The use of ILI without virological confirma-
tion tends to overestimate the ILI incidence rate but does
not introduce a differential age-related bias if one
assumes that the probability of a general practitioner
making a wrong diagnosis is same in all age groups.
We cannot rule out the existence of a differential bias
related to the use of different criteria for ILI and influ-
enza-related death between the two countries, but the
use of the age distribution of ILI and death would limit
any such bias.
The seasonal epidemics chosen for comparison with
the 2009 H1N1 pandemic date back between 20 and 30
years, and patient care no doubt evolved between 1978
and 2009, possibly impacting the incidence rates of mor-
bidity and mortality. However, once again, we focused
solely on the age distribution, which would be less
affected by advances in patient care: the highest attack
rate during seasonal epidemics is always observed among
young people and the highest mortality rate among
elderly people [23,24].
Although we studied only a few influenza seasons, the
age distributions of ILI and death were very similar to
those found in studies of several other influenza seasons
[25,26]. Unlike the incidence of ILI and death, which can
be highly variable from one influenza season to another
(even with the same subtype), the age distribution of ILI
and deaths is very similar across influenza seasons due to
a given subtype [8,25].
Our calculated relative illness ratios showed no major
differences between the 2009 H1N1 pandemic waves and
seasonal influenza epidemics, suggesting that the age dis-
tribution of risk of infection did not differ. This might be
explained either by similar age-to-age contact rates, or by
preexisting immunity in older subjects [27]. Several stud-
ies of the age distribution of ILI during seasonal epidem-
ics have shown that school-age children are most
susceptible to contracting influenza [8,28]. Studies of the
1918, 1957 and 1968 pandemics showed an age distribu-
tion of morbidity similar to that of seasonal epidemics
[29,30]. This is supported by a positive correlation
between age and seroprotection from influenza [25]. One
serological study showed that 30% of elderly people in the
US had neutralizing antibodies to the pandemic H1N1
virus, attributed to exposure to H1N1 viruses that circu-
lated until 1957, when H1N1 was replaced by a type A
H2N2 virus [6,31].
In contrast, the relative mortality ratios differed
between seasonal and 2009 H1N1 pandemic influenza.
During the pandemic waves, these ratios were consis-
tently above 1 among people under 60 years of age, peak-
ing under the age of 20 years. This age distribution of
mortality might be explained by lower preexisting immu-
nity to the pandemic H1N1 virus than to seasonal viruses
among the under-60s. However, we found that the RMR
declined between the ages of 20 and 60 years. Prior expo-
sure to seasonal influenza viruses thus seems to protect
against the 2009 pH1N1 virus. This is supported by two
studies, in which prior exposure to H1N1 seasonal type A
influenza strains provided partial immunity against 2009
pH1N1 infection [32,33].
The US H1N1 epidemic in winter 1978-79 was due to a
virus which re-emerged after a 20-year hiatus [8,28]. The
results shown in figure 2 suggest that individuals aged
over 20 years in 1978-79 were "protected" against this
variant. We obtained similar results for persons aged over
60 years during the 2009 H1N1 pandemic. Although one
study showed excess mortality due to the 2009 pH1N1
virus among the elderly [34], our findings are consistent
with the results of several other studies [3,6,35,36]. Many
elderly people would have had their immunity primed
during childhood ("original antigenic sin" [37]) by a virus
with similar antigenic properties.
Conclusion
In conclusion, the age distribution of influenza-like ill-
ness was similar between the 2009 H1N1 pandemic and
seasonal epidemics whereas the proportion of under-60s
among influenza deaths was markedly higher during the
2009 pandemic (peak <20 years) than during the seasonal
epidemics. However, a decrease of RMR between the age
of 20 and 60 years was detected. This points to immuno-
logical cross-reactivity between the H1N1 influenza
strain which circulated before 1957 and the 2009 pH1N1
strain, and also between seasonal influenza virus strains
and the 2009 pH1N1 virus. These findings may have con-
tributed to lowering the burden of the 2009 H1N1 pan-
demic but showed that young age was a principal
mortality risk factor of the 2009 pandemic.
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